An improved susceptibility test based on Amberlite reveals the potential antilisterial activity of fosfomycin in vitro

Canadian Journal of Microbiology

Volumn 59, Issue 4, 2013, Pages 252-259

  Han, Lei ^a   Lei, Jin'e ^a   Han, Shaoshan ^a   He, Li ^a   Ma, Chaofeng ^b   Yu, Pengbo ^a,c   Wu, Xiaokang ^a   Xu, Jiru ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b Xi'an Center for Disease Control and Prevention   (China)

^c Shaanxi Center for Disease Control and Prevention   (China)

Author keywords

Amberlite; Fosfomycin; Improved susceptibility test; Listeria monocytogenes

Indexed keywords

FOSFOMYCIN; LYSOPHOSPHOLIPASE; POLACRILIN;

ADSORPTION; ANTIBIOTIC RESISTANCE; ANTIBIOTICS; BACTERIUM; ENZYME ACTIVITY; INHIBITOR; MICROBIAL ACTIVITY; RESIN; TESTING METHOD;

AGAR DILUTION; ANTIBIOTIC SENSITIVITY; ARTICLE; BROTH DILUTION; DRUG SENSITIVITY; IN VITRO STUDY; LISTERIA MONOCYTOGENES; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 84876219569     PISSN: 00084166     EISSN: 14803275     Source Type: Journal    
DOI: 10.1139/cjm-2012-0742     Document Type: Article

References (48)

1. Allerberger, F., and Wagner, M. 2009. Listeriosis: a resurgent foodborne infection. Clin. Microbiol. Infect. 16(1): 16-23. doi:10.1111/j.1469-0691.2009.03109.x. PMID:20002687.
2. Aureli, P., Ferrini, A.M., Mannoni, V., Hodzic, S., Wedell-Weergaard, C., and Oliva, B. 2003. Susceptibility of Listeria monocytogenes isolated from food in Italy to antibiotics. Int. J. Food Microbiol. 83(3): 325-330. doi:10.1016/S0168-1605(02)00381-1. PMID:12745237.
3. Buchrieser, C., Rusniok, C., Garrido, P., Hain, T., Scortti, M., Lampidis, R., et al. 2011. Complete genome sequence of the animal pathogen Listeria ivanovii, which provides insights into host specificities and evolution of the genus Listeria. J. Bacteriol. 193(23): 6787-6788. doi:10.1128/JB.06120-11. PMID:22072644.
4. Cekmez, F., Tayman, C., Saglam, C., Cetinkaya, M., Bedir, O., Gnal, A., Tun, T., and Sarici, S.U. 2012. Well-known but rare pathogen in neonates: Listeria monocytogenes. Eur. Rev. Med. Pharmacol. Sci. 16(Suppl. 4): 58-61. PMID: 23090810.
5. Chalova, V.I., Crandall, P.G., and Ricke, S.C. 2010. Microbial inhibitory and radical scavenging activities of cold-pressed terpeneless Valencia orange (Citrus sinensis) oil in different dispersing agents. J. Sci. Food Agric. 90(5): 870-876. doi:10.1002/jsfa.3897. PMID:20355124.
6. Christensen, E.G., Gram, L., and Kastbjerg, V.G. 2011. Sublethal triclosan exposure decreases susceptibility to gentamicin and other aminoglycosides in Listeria monocytogenes. Antimicrob. Agents Chemother. 55(9): 4064-4071. doi: 10.1128/AAC.00460-11. PMID:21746948.
7. Clark, C.G., Farber, J., Pagotto, F., Ciampa, N., Dore, K., Nadon, C., et al. 2010. Surveillance for Listeria monocytogenes and listeriosis, 1995-2004. Epidemiol. Infect. 138(4): 559-572. doi:10.1017/S0950268809990914. PMID:19818199.
8. Clinical and Laboratory Standards Institute. 2009. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; Approved standard, eighth edition (M07-A8). Clinical and Laboratory Standards Institute, Wayne, Pennsylvania.
9. Clinical and Laboratory Standards Institute. 2010. Performance standards for antimicrobial susceptibility testing; twentieth informational supplement (M100-S20). Clinical and Laboratory Standards Institute, Wayne, Pennsylvania.
10. de las Heras, A., Cain, R.J., Bielecka, M.K., and Vazquez-Boland, J.A. 2011. Regulation of Listeria virulence: PrfA master and commander. Curr. Opin. Microbiol. 14(2): 118-127. doi:10.1016/j.mib.2011.01.005. PMID:21388862.
11. Del Pozo, J.L., de la Garza, R.G., Rada, P.D., Ornilla, E., and Yuste, J.R. 2013. Listeria monocytogenes septic arthritis in a patient treated with mycophenolate mofetil for polyarteritis nodosa: a case report and review of the literature. Int. J. Infect. Dis. 17: e132-e133. doi:10.1016/j.ijid.2012.11.005. PMID:23218550.
12. den Bakker, H.C., Cummings, C.A., Ferreira, V., Vatta, P., Orsi, R.H., Degoricija, L., et al. 2010. Comparative genomics of the bacterial genus Listeria: Genome evolution is characterized by limited gene acquisition and limited gene loss. BMC Genomics, 11: 688. doi:10.1186/1471-2164-11-688. PMID: 21126366.
13. Ermolaeva, S., Karpova, T., Novella, S., Wagner, M., Scortti, M., Tartakovskii, I., and Vazquez-Boland, J.A. 2003. A simple method for the differentiation of Listeria monocytogenes based on induction of lecithinase activity by charcoal. Int. J. Food Microbiol. 82(1): 87-94. doi:10.1016/S0168-1605(02)00399-9. PMID: 12505463.
14. Ermolaeva, S., Novella, S., Vega, Y., Ripio, M.T., Scortti, M., and Vazquez- Boland, J.A. 2004. Negative control of Listeria monocytogenes virulence genes by a diffusible autorepressor. Mol. Microbiol. 52(2): 601-611. doi:10.1111/j.1365-2958.2004.04003.x. PMID:15066044.
15. Fillgrove, K.L., Pakhomova, S., Newcomer, M.E., and Armstrong, R.N. 2003. Mechanistic diversity of fosfomycin resistance in pathogenic microorganisms. J. Am. Chem. Soc. 125(51): 15730-15731. doi:10.1021/ja039307z. PMID: 14677948.
16. Goldfeder, Y., Zaknoon, F., and Mor, A. 2010. Experimental conditions that enhance potency of an antibacterial oligo-acyl-lysyl. Antimicrob. Agents Chemother. 54(6): 2590-2595. doi:10.1128/AAC.01656-09. PMID:20385856.
17. Gomez, N.C., Abriouel, H., Grande, M.A., Pulido, R.P., and Galvez, A. 2012. Effect of enterocin AS-48 in combination with biocides on planktonic and sessile Listeria monocytogenes. Food Microbiol. 30(1): 51-58. doi:10.1016/j.fm.2011.12.013. PMID:22265283.
18. Gray, M.J., Freitag, N.E., and Boor, K.J. 2006. How the bacterial pathogen Listeria monocytogenes mediates the switch from environmental Dr. Jekyll to pathogenic Mr. Hyde. Infect. Immun. 74(5): 2505-2512. doi:10.1128/IAI.74.5.2505-2512.2006. PMID:16622185.
19. Guevara, R.E., Mascola, L., and Sorvillo, F. 2009. Risk factors for mortality among patients with nonperinatal listeriosis in Los Angeles County, 1992-2004. Clin. Infect. Dis. 48(11): 1507-1515. doi:10.1086/598935. PMID:19400687.
20. Hof, H. 2003. Listeriosis: therapeutic options. FEMS Immunol. Med. Microbiol. 35(3): 203-205. doi:10.1016/S0928-8244(02)00466-2. PMID:12648838.
21. Hof, H., Nichterlein, T., and Kretschmar, M. 1997. Management of listeriosis. Clin. Microbiol. Rev. 10(2): 345-357. PMID:9105758.
22. Ikeda-Dantsuji, Y., Nakae, T., Ariyoshi, K., Mizuno, H., Moriyama, H., Nagura, O., et al. 2012. Limited detectability of linezolid-resistant Staphylococcus aureus by the Etest method and its improvement using enriched media. J. Med. Microbiol. 61(Pt 7): 998-1002. doi:10.1099/jmm.0.043695-0. PMID:22493282.
23. Kahan, F.M., Kahan, J.S., Cassidy, P.J., and Kropp, H. 1974. The mechanism of action of fosfomycin (phosphonomycin). Ann. N.Y. Acad. Sci. 235: 364-386. doi:10.1111/j.1749-6632.1974.tb43277.x. PMID:4605290.
24. Klancnik, A., Piskernik, S., Jersek, B., and Mozina, S.S. 2010. Evaluation of diffusion and dilution methods to determine the antibacterial activity of plant extracts. J. Microbiol. Methods, 81(2): 121-126. doi:10.1016/j.mimet.2010.02. 004. PMID:20171250.
25. Li, Q., Sherwood, J.S., and Logue, C.M. 2007. Antimicrobial resistance of Listeria spp. recovered from processed bison. Lett. Appl. Microbiol. 44(1): 86-91. doi: 10.1111/j.1472-765X.2006.02027.x. PMID:17209820.
26. -ΔΔCT method. Methods 25(4): 402-408. doi:10.1006/meth.2001.1262. PMID:11846609.
27. MacGowan, A.P., Holt, H.A., Bywater, M.J., and Reeves, D.S. 1990. In vitro antimicrobial susceptibility of Listeria monocytogenes isolated in the UK and other Listeria species. Eur. J. Clin. Microbiol. Infect. Dis. 9(10): 767-770. doi:10.1007/ BF02184692. PMID:2124539.
28. Martinez, B., and Rodriguez, A. 2005. Antimicrobial susceptibility of nisin resistant Listeria monocytogenes of dairy origin. FEMS Microbiol. Lett. 252(1): 67-72. doi:10.1016/j.femsle.2005.08.025. PMID:16165322.
29. Mertins, S., Joseph, B., Goetz, M., Ecke, R., Seidel, G., Sprehe, M., et al. 2007. Interference of components of the phosphoenolpyruvate phosphotransferase system with the central virulence gene regulator PrfA of Listeria monocytogenes. J. Bacteriol. 189(2): 473-490. doi:10.1128/JB.00972-06. PMID:17085572.
30. Michalopoulos, A.S., Livaditis, I.G., and Gougoutas, V. 2011. The revival of fosfomycin. Int. J. Infect. Dis. 15(11): e732-739. doi:10.1016/j.ijid.2011.07.007. PMID: 21945848.
31. Miya, S., Takahashi, H., Ishikawa, T., Fujii, T., and Kimura, B. 2010. Risk of Listeria monocytogenes contamination of raw ready-to-eat seafood products available at retail outlets in Japan. Appl. Environ. Microbiol. 76(10): 3383-3386. doi:10. 1128/AEM.01456-09. PMID:20348310.
32. Mook, P., Patel, B., and Gillespie, I.A. 2012. Risk factors for mortality in nonpregnancy- related listeriosis. Epidemiol. Infect. 140(4): 706-715. doi:10.1017/ S0950268811001051. PMID:21733248.
33. Okada, N., Nishio, M., and Danbara, H. 2003. Intracellular activity of fosfomycin against two distinct enteropathogenic bacteria, Salmonella enterica and Listeria monocytogenes, alive inside host cells. Chemotherapy, 49(1-2): 49-55. doi:10. 1159/000069787. PMID:12714811.
34. Popovic, M., Steinort, D., Pillai, S., and Joukhadar, C. 2010. Fosfomycin: an old, new friend? Eur. J. Clin. Microbiol. Infect. Dis. 29(2): 127-142. doi:10.1007/s10096-009-0833-2. PMID:19915879.
35. Rocourt, J., Hogue, A., Toyofuku, H., Jacquet, C., and Schlundt, J. 2001. Listeria and listeriosis: risk assessment as a new tool to unravel a multifaceted problem. Am. J. Infect. Control, 29(4): 225-227. doi:10.1067/mic.2001.115681. PMID:11486259.
36. Salvucci, E., Hebert, E.M., Sesma, F., and Saavedra, L. 2010. Combined effect of synthetic enterocin CRL35 with cell wall, membrane-acting antibiotics and muranolytic enzymes against Listeria cells. Lett. Appl. Microbiol. 51(2): 191-195. doi:10.1111/j.1472-765X.2010.02879.x. PMID:20672439.
37. Schindler, J., and Langsadl, L. 1979. Fosfomycin therapy of experimental infections in mice. Zentralbl. Bakteriol. Orig. A, 243(1): 136-139. PMID:375622.
38. Scortti, M., Lacharme-Lora, L., Wagner, M., Chico-Calero, I., Losito, P., and Vazquez-Boland, J.A. 2006. Coexpression of virulence and fosfomycin susceptibility in Listeria: molecular basis of an antimicrobial in vitro - in vivo paradox. Nat. Med. 12(5): 515-517. doi:10.1038/nm1396. PMID:16633349.
39. Scortti, M., Monzo, H.J., Lacharme-Lora, L., Lewis, D.A., and Vazquez-Boland, J.A. 2007. The PrfA virulence regulon. Microbes. Infect. 9(10): 1196-1207. doi:10.1016/j.micinf.2007.05.007. PMID:17764998.
40. Temple, M.E., and Nahata, M.C. 2000. Treatment of listeriosis. Ann. Pharmacother. 34(5): 656-661. doi:10.1345/aph.19315. PMID:10852095.
41. To, M.S., Favrin, S., Romanova, N., and Griffiths, M.W. 2002. Postadaptational resistance to benzalkonium chloride and subsequent physicochemical modifications of Listeria monocytogenes. Appl. Environ. Microbiol. 68(11): 5258-5264. doi:10.1128/AEM.68.11.5258-5264.2002. PMID:12406712.
42. Todorov, S.D., Furtado, D.N., Saad, S.M., and Gombossy de Melo Franco, B.D. 2011. Bacteriocin production and resistance to drugs are advantageous features for Lactobacillus acidophilus La-14, a potential probiotic strain. New Microbiol. 34(4): 357-370.PMID:22143809.
43. Troxler, R., von Graevenitz, A., Funke, G., Wiedemann, B., and Stock, I. 2000. Natural antibiotic susceptibility of Listeria species: L. grayi, L innocua, L. ivanovii, L. monocytogenes, L. seeligeri and L. welshimeri strains. Clin. Microbiol. Infect. 6(10): 525-535. doi:10.1046/j.1469-0691.2000.00168.x. PMID:11168046.
44. Vallet, C.M., Marquez, B., Ngabirano, E., Lemaire, S., Mingeot-Leclercq, M.P., Tulkens, P.M., and Van Bambeke, F. 2011. Cellular accumulation of fluoroquinolones is not predictive of their intracellular activity: studies with gemifloxacin, moxifloxacin and ciprofloxacin in a pharmacokinetic/pharmacodynamic model of uninfected and infected macrophages. Int. J. Antimicrob. Agents, 38(3): 249-256. doi:10.1016/j.ijantimicag.2011.05.011. PMID:21764262.
45. Vasilev, V., Japheth, R., Andorn, N., Yshai, R., Agmon, V., Gazit, E., et al. 2009. A survey of laboratory-confirmed isolates of invasive listeriosis in Israel, 1997-2007. Epidemiol. Infect. 137(4): 577-580. doi:10.1017/S0950268808001179. PMID:18796168.
46. Vazquez-Boland, J.A., Dominguez-Bernal, G., Gonzalez-Zorn, B., Kreft, J., and Goebel, W. 2001. Pathogenicity islands and virulence evolution in Listeria. Microbes Infect. 3(7): 571-584. doi:10.1016/S1286-4579(01)01413-7. PMID:11418331.
47. Velge, P., Herler, M., Johansson, J., Roche, S.M., Temoin, S., Fedorov, A.A., et al. 2007. A naturally occurring mutation K220T in the pleiotropic activator PrfA of Listeria monocytogenes results in a loss of virulence due to decreasing DNAbinding affinity. Microbiology (Reading, England), 153(4): 995-1005. doi:10.1099/mic.0.2006/002238-0. PMID:17379709.
48. Wiegand, I., Hilpert, K., and Hancock, R.E. 2008. Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nat. Protoc. 3(2): 163-175. doi:10.1038/nprot.2007.521. PMID:18274517.